Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 217.4% in March

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 61,900 shares, a growth of 217.4% from the March 15th total of 19,500 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 213,100 shares, the short-interest ratio is presently 0.3 days.

Terumo Price Performance

Shares of TRUMY traded up $0.65 during mid-day trading on Friday, reaching $19.02. 157,283 shares of the company's stock were exchanged, compared to its average volume of 196,195. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. Terumo has a 52-week low of $14.06 and a 52-week high of $21.22. The company has a market cap of $28.16 billion, a price-to-earnings ratio of 39.68 and a beta of 0.76. The company has a 50-day simple moving average of $18.36 and a two-hundred day simple moving average of $19.09.

Terumo (OTCMKTS:TRUMY - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.16 earnings per share for the quarter. The company had revenue of $1.73 billion during the quarter.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.